Abstract:Microglia and monocytes adopt disease‐specific signatures in CNS disease. These are composed of differing proportions of unique subtypes. Cd81 is an inflammatory‐stable, microglia‐enriched gene that accurately distinguishes them from monocytes. Microglia and bone marrow‐derived monocytes are key elements of central nervous system (CNS) inflammation, both capable of enhancing and dampening immune‐mediated pathology. However, the study‐specific focus on individual cell types, disease models or experimental approaches has limited our ability to infer common and disease‐specific responses. This meta‐analysis integrates bulk and single‐cell transcriptomic datasets of microglia and monocytes from disease models of autoimmunity, neurodegeneration, sterile injury, and infection to build a comprehensive resource connecting myeloid responses across CNS disease. We demonstrate that the bulk microglial and monocyte program is highly contingent on the disease environment, challenging the notion of a universal microglial disease signature. Integration of six single‐cell RNA‐sequencing datasets revealed that these disease‐specific signatures are likely driven by differing proportions of unique myeloid subpopulations that were individually expanded in different disease settings. These subsets were functionally‐defined as neurodegeneration‐associated, inflammatory, interferon‐responsive, phagocytic, antigen‐presenting, and lipopolysaccharide‐responsive cellular states, revealing a core set of myeloid responses at the single‐cell level that are conserved across CNS pathology. Showcasing the predictive and practical value of this resource, we performed differential expression analysis on microglia and monocytes across disease and identified Cd81 as a new neuroinflammatory‐stable gene that accurately identified microglia and distinguished them from monocyte‐derived cells across all experimental models at both the bulk and single‐cell level. Together, this resource dissects the influence of disease environment on shared immune response programmes to build a unified perspective of myeloid behavior across CNS pathology.

Mechanisms of myeloid cell entry to the healthy and diseased central nervous system

Myeloid Cells in the Central Nervous System

The niche matters: origin, function and fate of CNS-associated macrophages during health and disease

Meningeal Immunity and Neurological Diseases: New Approaches, New Insights

CNS and CNS Diseases in Relation to Their Immune System

Macrophages at CNS interfaces: ontogeny and function in health and disease

Mechanisms of Dendritic Cell Trafficking Across the Blood–brain Barrier

Immune cells as messengers from the CNS to the periphery: the role of the meningeal lymphatic system in immune cell migration from the CNS

Immune dynamics in the CNS and its barriers during homeostasis and disease

Emergence of the brain-border immune niches and their contribution to the development of neurodegenerative diseases

Immune regulation within the central nervous system

Molecular and Cellular Mechanisms for Microbial Entry into the CNS

Integrating transcriptomic datasets across neurological disease identifies unique myeloid subpopulations driving disease‐specific signatures

Guardians of CNS Homeostasis

Immune cell compartmentalization for brain surveillance and protection

Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution

Basic principles of neuroimmunology

Endothelial cells and macrophages as allies in the healthy and diseased brain

CNS Macrophages and Infant Infections

Species differences in immune‐mediated CNS tissue injury and repair: A (neuro)inflammatory topic

Infiltration by monocytes of the central nervous system and its role in multiple sclerosis: reflections on therapeutic strategies